Prostate specific antigen in patients of benign prostate hypertrophy and carcinoma prostate
Authors:
- 1 March 2006
- journal article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 21 (1) , 34-40
Abstract
Prostate Specific Antigen (PSA) has emerged as the most applicable and important tumor marker for carcinoma prostate. In the present study PSA was determined in serum of healthy subjects, patients of benign prostate hypertrophy (BPH) and Carcinoma Prostate (Ca−P) to evaluate its diagnostic efficiency in day to day management of prostate cancer patients and in differentiating patients of early prostate cancer from those with BPH. Receiver operating characteristic curve (ROC) revealed 2 ng/ml and 10 ng/ml cut off serum PSA level for BPH and untreated carcinoma prostate patients (Ca−P). An extremely significant increase (P<0.0001) was observed in mean PSA concentration in BPH patients and adenocarcinoma prostate patients when compared to healthy males. Clinical relevance of PSA was highlighted by a case study of cancer patient prior to any therapy till death.Keywords
This publication has 19 references indexed in Scilit:
- Stability of total and free prostate specific antigen in serum samples at different storage conditionsIndian Journal of Clinical Biochemistry, 2004
- Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian malesIndian Journal of Clinical Biochemistry, 2004
- Comparative Analysis of Complexed Prostate Specific Antigen, Free Prostate Specific Antigen and Their Ratio in Detecting Prostate CancerJournal of Urology, 2002
- INTERPRETATION OF FREE PROSTATE SPECIFIC ANTIGEN CLINICAL RESEARCH STUDIES FOR THE DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black MenNew England Journal of Medicine, 1996
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993
- Risk Factors for Prostate CancerAnnals of Internal Medicine, 1993
- Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.1989
- EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR ADENOCARCINOMA OF THE PROSTATE1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987